» Articles » PMID: 27411923

Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer

Overview
Specialty Oncology
Date 2016 Jul 15
PMID 27411923
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to unveil the clinical roles and biological function of lncRNA TUBA4B in on-small cell lung cancer (NSCLC). The relative expression level of TUBA4B was estimated by qPCR in 114 pairs of NSCLC and NT samples and the relation of TUBA4B to clinical data of NSCLC patients was analyzed. We found TUBA4B was lower expressed in NSCLC and five cell lines. The lower expression of TUBA4B was remarkably correlated with advanced TNM stage and lymph node metastasis and served as a predictor for overall survival of NSCLC. After overexpression of TUBA4B, cell proliferation ability of A549 and NCI-H1299 remarkably decreased. Our study ascertained low expression TUBA4B in NSCLC tissue, cell lines and is a poor predictor for prognosis and can regulate cell proliferation in NSCLC.

Citing Articles

Downregulated expression of lncRNA TUBA4B predicts unfavorable prognosis and suppresses glioma progression by sponging miR-183 to regulate SMAD4 expression.

Bao X, Wang S, Li Y Arch Med Sci. 2024; 20(3):863-875.

PMID: 39050167 PMC: 11264155. DOI: 10.5114/aoms.2020.92817.


MiR-210 regulates lung adenocarcinoma by targeting HIF-1α.

Cao G, Fan P, Ma R, Wang Q, He L, Niu H Heliyon. 2023; 9(5):e16079.

PMID: 37215862 PMC: 10192744. DOI: 10.1016/j.heliyon.2023.e16079.


Heterogeneous microenvironment analysis to explore the potential regulatory role of endothelial-mesenchymal transition in idiopathic pulmonary fibrosis.

Xu Y, Hu X, Zhang Y, Pan Z, Sun Z, Huang Z Ann Transl Med. 2022; 10(8):486.

PMID: 35571445 PMC: 9096361. DOI: 10.21037/atm-22-1438.


GraphSynergy: a network-inspired deep learning model for anticancer drug combination prediction.

Yang J, Xu Z, Wu W, Chu Q, Zhang Q J Am Med Inform Assoc. 2021; 28(11):2336-2345.

PMID: 34472609 PMC: 8510276. DOI: 10.1093/jamia/ocab162.


LINC01619 promotes non-small cell lung cancer development via regulating PAX6 by suppressing microRNA-129-5p.

Liu Z, Han L, Yu H, Gao N, Xin H Am J Transl Res. 2020; 12(6):2538-2553.

PMID: 32655789 PMC: 7344070.


References
1.
Ogawa E, Takenaka K, Katakura H, Adachi M, Otake Y, Toda Y . Perimembrane Aurora-A expression is a significant prognostic factor in correlation with proliferative activity in non-small-cell lung cancer (NSCLC). Ann Surg Oncol. 2007; 15(2):547-54. PMC: 2244700. DOI: 10.1245/s10434-007-9653-8. View

2.
Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

3.
Jemal A, Murray T, Ward E, Samuels A, Tiwari R, Ghafoor A . Cancer statistics, 2005. CA Cancer J Clin. 2005; 55(1):10-30. DOI: 10.3322/canjclin.55.1.10. View

4.
Gridelli C, Rossi A, Maione P . Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents. Oncogene. 2003; 22(42):6629-38. DOI: 10.1038/sj.onc.1206957. View

5.
Fu X, Ravindranath L, Tran N, Petrovics G, Srivastava S . Regulation of apoptosis by a prostate-specific and prostate cancer-associated noncoding gene, PCGEM1. DNA Cell Biol. 2006; 25(3):135-41. DOI: 10.1089/dna.2006.25.135. View